3,4-dihydroxyphenylacetic acid has been researched along with Dementia Praecox in 51 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risperidone treatment induced a decrement of plasma DA levels and increments of plasma DOPAC and DA TR in the total group of schizophrenic patients." | 5.37 | Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment. ( Cai, HL; Fang, PF; Hu, L; Li, HD; Yang, W; Ye, HS; Zhang, XH, 2011) |
| "Clozapine is an atypical neuroleptic medication with superior efficacy to conventional antipsychotic agents for patients with chronic, symptomatic schizophrenia." | 5.07 | The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. ( Breier, A; Buchanan, RW; Goldstein, DS; Holmes, C; Listwak, S; Waltrip, RW, 1994) |
| "In this study, plasma obtained from monozygotic twin pairs discordant for schizophrenia (n = 10) or major affective disorder (n = 3) was assayed for epinephrine, norepinephrine, dihydroxyphenylacetic acid, homovanillic acid, adrencorticotropin hormone, and cortisol." | 3.71 | Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. ( Bonsall, R; Walder, DJ; Walker, EF, 2002) |
| "The dopamine metabolite, 3,4-dihydroxyphenylacetic acid (DOPAC), was found to be decreased in the anterior cingulate cortex of individuals with schizophrenia compared with normal controls." | 3.69 | Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia. ( Casanova, MF; Karoum, F; Wyatt, RJ, 1995) |
| "The authors report cerebrospinal fluid (CSF) concentrations of five monoamine metabolites before and after probenecid administration in normal subjects and patients with depression and schizophrenia." | 3.66 | CSF monoamine metabolites in depression and schizophrenia. ( Anderson, PJ; Barchas, JD; Berger, PA; Davis, KL; Faull, KF; Kilkowski, J; Kraemer, H, 1980) |
| "Schizophrenia is probably ascribed to perinatal neurodevelopmental deficits, and its onset might be affected by environmental factors." | 1.62 | Preventive role of regular low-intensity exercise during adolescence in schizophrenia model mice with abnormal behaviors. ( Hata, T; Hiraga, T; Koizumi, H; Mouri, A; Nabeshima, T; Oharomari, LK; Okamoto, M; Shima, T; Soya, H; Yook, JS, 2021) |
| "Some individuals with schizophrenia present with a dopamine supersensitivity state (DSS) induced by a long-term administration of excessive antipsychotics; this is recognized as dopamine supersensitivity psychosis (DSP)." | 1.62 | Reduction of dopamine and glycogen synthase kinase-3 signaling in rat striatum after continuous administration of haloperidol. ( Hashimoto, K; Hirose, Y; Iyo, M; Kanahara, N; Kimura, H; Kimura, M; Nangaku, M; Niitsu, T; Oda, Y; Shirayama, Y, 2021) |
| "Risperidone treatment induced a decrement of plasma DA levels and increments of plasma DOPAC and DA TR in the total group of schizophrenic patients." | 1.37 | Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment. ( Cai, HL; Fang, PF; Hu, L; Li, HD; Yang, W; Ye, HS; Zhang, XH, 2011) |
| " Chronic administration of clozapine (5 mg/kg s." | 1.36 | Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia. ( Cilia, J; Dawson, LA; Gartlon, JE; Jones, DN; Moore, SH; Shilliam, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (52.94) | 18.7374 |
| 1990's | 9 (17.65) | 18.2507 |
| 2000's | 7 (13.73) | 29.6817 |
| 2010's | 6 (11.76) | 24.3611 |
| 2020's | 2 (3.92) | 2.80 |
| Authors | Studies |
|---|---|
| Koizumi, H | 1 |
| Hiraga, T | 1 |
| Oharomari, LK | 1 |
| Hata, T | 1 |
| Shima, T | 1 |
| Yook, JS | 1 |
| Okamoto, M | 1 |
| Mouri, A | 1 |
| Nabeshima, T | 2 |
| Soya, H | 1 |
| Kimura, M | 1 |
| Oda, Y | 1 |
| Kimura, H | 1 |
| Nangaku, M | 1 |
| Hirose, Y | 1 |
| Niitsu, T | 1 |
| Kanahara, N | 1 |
| Shirayama, Y | 1 |
| Hashimoto, K | 2 |
| Iyo, M | 1 |
| Iwata, Y | 1 |
| Suzuki, K | 1 |
| Wakuda, T | 1 |
| Seki, N | 1 |
| Thanseem, I | 1 |
| Matsuzaki, H | 1 |
| Mamiya, T | 1 |
| Ueki, T | 1 |
| Mikawa, S | 1 |
| Sasaki, T | 1 |
| Suda, S | 1 |
| Yamamoto, S | 1 |
| Tsuchiya, KJ | 1 |
| Sugihara, G | 1 |
| Nakamura, K | 1 |
| Sato, K | 1 |
| Takei, N | 1 |
| Mori, N | 1 |
| Winter, C | 1 |
| Djodari-Irani, A | 1 |
| Sohr, R | 1 |
| Morgenstern, R | 1 |
| Feldon, J | 2 |
| Juckel, G | 1 |
| Meyer, U | 1 |
| Cilia, J | 1 |
| Gartlon, JE | 1 |
| Shilliam, C | 1 |
| Dawson, LA | 1 |
| Moore, SH | 1 |
| Jones, DN | 1 |
| Nikisch, G | 1 |
| Baumann, P | 1 |
| Kiessling, B | 1 |
| Reinert, M | 1 |
| Wiedemann, G | 1 |
| Kehr, J | 1 |
| Mathé, AA | 1 |
| Piel, M | 1 |
| Roesch, F | 1 |
| Weisser, H | 1 |
| Schneider, P | 1 |
| Hertel, A | 1 |
| Cai, HL | 1 |
| Fang, PF | 1 |
| Li, HD | 1 |
| Zhang, XH | 1 |
| Hu, L | 1 |
| Yang, W | 1 |
| Ye, HS | 1 |
| Liu, Y | 1 |
| Tang, Y | 1 |
| Pu, W | 1 |
| Zhang, X | 1 |
| Zhao, J | 1 |
| Kucinski, A | 1 |
| Syposs, C | 1 |
| Wersinger, S | 1 |
| Bencherif, M | 1 |
| Stachowiak, MK | 1 |
| Stachowiak, EK | 1 |
| Brown, PL | 1 |
| Shepard, PD | 1 |
| Elmer, GI | 1 |
| Stockman, S | 1 |
| McFarland, R | 1 |
| Mayo, CL | 1 |
| Cadet, JL | 1 |
| Krasnova, IN | 1 |
| Greenwald, M | 1 |
| Schoonover, C | 1 |
| Vogel, MW | 1 |
| Alquicer, G | 1 |
| Silva-Gómez, AB | 1 |
| Peralta, F | 1 |
| Flores, G | 1 |
| DeLisi, LE | 1 |
| Mirsky, AF | 1 |
| Buchsbaum, MS | 1 |
| van Kammen, DP | 3 |
| Berman, KF | 1 |
| Caton, C | 1 |
| Kafka, MS | 1 |
| Ninan, PT | 1 |
| Phelps, BH | 1 |
| Karoum, F | 4 |
| Owen, F | 2 |
| Baker, HF | 1 |
| Ridley, RM | 1 |
| Cross, AJ | 2 |
| Crow, TJ | 2 |
| Jeste, DV | 1 |
| Doongaji, DR | 1 |
| Linnoila, M | 5 |
| Seppala, T | 3 |
| Scheinin, M | 2 |
| Capone, A | 1 |
| Koulu, M | 1 |
| Kobayashi, K | 1 |
| Koide, Y | 1 |
| Shohmori, T | 1 |
| Berger, PA | 2 |
| Faull, KF | 2 |
| Kilkowski, J | 2 |
| Anderson, PJ | 2 |
| Kraemer, H | 2 |
| Davis, KL | 2 |
| Barchas, JD | 2 |
| Kontur, PJ | 1 |
| al-Tikriti, M | 1 |
| Innis, RB | 1 |
| Roth, RH | 3 |
| Kitaichi, K | 1 |
| Yamada, K | 1 |
| Hasegawa, T | 1 |
| Furukawa, H | 1 |
| Wyatt, RJ | 3 |
| Casanova, MF | 1 |
| Louilot, A | 1 |
| Le Moal, M | 1 |
| Breier, A | 1 |
| Buchanan, RW | 1 |
| Waltrip, RW | 1 |
| Listwak, S | 1 |
| Holmes, C | 1 |
| Goldstein, DS | 1 |
| Rubin, LS | 1 |
| Prell, GD | 1 |
| Green, JP | 1 |
| Elkashef, AM | 1 |
| Khandelwal, JK | 1 |
| Lawson, WB | 1 |
| Jaeger, AC | 1 |
| Kaufmann, CA | 1 |
| Kirch, DG | 1 |
| King, D | 1 |
| Zigmond, MJ | 1 |
| Finlay, JM | 1 |
| Jentsch, JD | 1 |
| Taylor, JR | 1 |
| Uehara, T | 1 |
| Tanii, Y | 1 |
| Sumiyoshi, T | 1 |
| Kurachi, M | 1 |
| Murphy, CA | 1 |
| Pezze, M | 1 |
| Heidbreder, C | 1 |
| Balla, A | 1 |
| Koneru, R | 1 |
| Smiley, J | 1 |
| Sershen, H | 1 |
| Javitt, DC | 1 |
| Walker, EF | 1 |
| Bonsall, R | 1 |
| Walder, DJ | 1 |
| Bacopoulos, NC | 1 |
| Spokes, EG | 1 |
| Bird, ED | 1 |
| Westerink, BH | 1 |
| Korf, J | 1 |
| Wilk, S | 2 |
| Stanley, M | 2 |
| Clow, A | 1 |
| Jenner, P | 1 |
| Theodorou, A | 1 |
| Marsden, CD | 1 |
| Rotrosen, J | 1 |
| Angrist, BM | 1 |
| Gershon, S | 1 |
| Aronson, M | 1 |
| Gruen, P | 1 |
| Sachar, EJ | 1 |
| Denning, RK | 1 |
| Matthysse, S | 1 |
| Goodwin, FK | 1 |
| Post, RM | 1 |
| Hoehn, MM | 1 |
| Crowley, TJ | 1 |
| Rutledge, CO | 1 |
| Peters, J | 1 |
| van Kammen, WB | 2 |
| Widerlöv, E | 1 |
| Frecska, E | 3 |
| Bagdy, G | 3 |
| Perenyi, A | 3 |
| Arato, M | 2 |
| Degrell, I | 1 |
| Mogyorosy, Z | 1 |
| Révai, K | 2 |
| Papp, Z | 1 |
| Fekete, MI | 1 |
| Ferrier, IN | 1 |
| Johnson, JA | 1 |
| Johnstone, EC | 1 |
| Owens, DG | 1 |
| Poulter, M | 1 |
| Contreras, SA | 2 |
| Maas, JW | 2 |
| Seleshi, E | 2 |
| Bowden, CL | 2 |
| Davila, R | 1 |
| Zumarraga, M | 1 |
| Perea, K | 1 |
| Andia, I | 1 |
| Friedhoff, AJ | 1 |
| Mann, LS | 1 |
| Bridge, TP | 2 |
| Kleinman, JE | 2 |
| Soldo, BJ | 1 |
3 reviews available for 3,4-dihydroxyphenylacetic acid and Dementia Praecox
| Article | Year |
|---|---|
Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antidepressive Agents, Tricyclic; Bipolar Disorder; Brain; Depressio | 1975 |
Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antipsychotic Agents; Catecholamines; Cyclic AMP; Dopamine; Dopamine | 1986 |
A critical appraisal of CSF monoamine metabolite studies in schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Biogenic Monoamines; Dopamine; Homovanillic Acid; Humans; Hydroxyind | 1988 |
3 trials available for 3,4-dihydroxyphenylacetic acid and Dementia Praecox
| Article | Year |
|---|---|
Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Benzamides; Biogenic Monoamines; Brain | 2010 |
The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenocorticotropic Hormone; Adult; Analysis of Variance; Clozapine; | 1994 |
Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Apomorphine; Chronic Disease; Clinical Trials as Topic; Diben | 1988 |
45 other studies available for 3,4-dihydroxyphenylacetic acid and Dementia Praecox
| Article | Year |
|---|---|
Preventive role of regular low-intensity exercise during adolescence in schizophrenia model mice with abnormal behaviors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Behavior, Animal; Disease Models, Animal; Dopa | 2021 |
Reduction of dopamine and glycogen synthase kinase-3 signaling in rat striatum after continuous administration of haloperidol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Corpus Striatum; Dopamine; Glycogen S | 2021 |
Irradiation in adulthood as a new model of schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Animals; Behavior, Animal; Disease Models, Animal; Dopa | 2008 |
Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Brain Diseases; Chromatography, High Press | 2009 |
Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Antipsychotic Agents; Brain Chemistry; Disease | 2010 |
Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Analysis of Variance; Antipsychotic Agents; Biogenic Monoamin | 2011 |
Concentration change of DA, DOPAC, Glu and GABA in brain tissues in schizophrenia developmental model rats induced by MK-801.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Brain; Dizocilpine Maleate; Dopamine; gam | 2011 |
α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acoustic Stimulation; Animals; Chromatography, High Pressure Liquid; | 2012 |
Altered spatial learning, cortical plasticity and hippocampal anatomy in a neurodevelopmental model of schizophrenia-related endophenotypes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cytarabine; Disease Models, Animal; Dopamine; Endophenotype | 2012 |
Neonatal ventral hippocampus lesion alters the dopamine content in the limbic regions in postpubertal rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Behavior, Animal; Denervation; Dis | 2004 |
The Genain Quadruplets 25 years later: a diagnostic and biochemical followup.
Topics: 3,4-Dihydroxyphenylacetic Acid; Cyclic AMP; Dopamine beta-Hydroxylase; Environment; Female; Follow-U | 1984 |
Effect of chronic amphetamine administration on dopaminergic systems in the vervet brain: relationship to findings in the brains of schizophrenics.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Brain; Chlorocebus aethiops; Dopa Decarboxyla | 1983 |
Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Homovan | 1984 |
Liquid chromatographic assay for CSF catecholamines using electrochemical detection.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Dopamine; Humans; Mac | 1984 |
Determination of conjugated dopamine in cerebrospinal fluid from humans and non-human primates with high performance liquid chromatography using electrochemical detection.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Dopamine; Epinephrine | 1984 |
Determination of p-hydroxyphenylacetic acid in cerebrospinal fluid by high-performance liquid chromatography with electrochemical detection.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Aged; Child; Child, Preschool; Chromatography, Ge | 1982 |
CSF monoamine metabolites in depression and schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Depression; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mal | 1980 |
Postmortem stability of monoamines, their metabolites, and receptor binding in rat brain regions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Brain Chemistry; Dopamine; Huma | 1994 |
Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; | 1994 |
Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Age Factors; Aged; Antipsychotic Agents; Autopsy; Female; Gas | 1995 |
Lateralized interdependence between limbicotemporal and ventrostriatal dopaminergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine D2 Rec | 1994 |
Power to the cingulate.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Gyrus Cinguli; Humans; Models, Statistical; Re | 1996 |
The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patients.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Biogenic Amines; Chronic Disease; Drinking; Female; Histamine | 1996 |
Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Disease Models, Animal; Dopamine; Dopamine Age | 1997 |
Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Brain; Dextroamphetamine; Disease Mod | 1998 |
Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Animals, Newborn; Brain; Caudate Nucleus; Disease | 2000 |
Differential involvement of dopamine in the shell and core of the nucleus accumbens in the expression of latent inhibition to an aversively conditioned stimulus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Avoidance Learning; Behavior, Animal; Conditioning, Psychol | 2000 |
Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Central Nervous System Stimulants; Corpus Stri | 2001 |
Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adrenocorticotropic Hormone; Adult; Bipolar Disorder; Ca | 2002 |
Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antipsychotic Agents; Brain; Cerebral Cortex; Dopamine; Homovanillic | 1979 |
Dopamine and schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Dopamine; Homovanillic Acid; Humans; Rats; | 1976 |
Dopamine and schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Corpus Striatum; Drug Evaluation; Hom | 1977 |
Neuroleptic drugs and the dopamine hypothesis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Limbi | 1979 |
Thiethylperazine; clinical antipsychotic efficacy and correlation with potency in predictive systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Corpus Striatum; Dopamine; Dopamine Anta | 1978 |
The Parkinsonian syndrome and its dopamine correlates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dopamine; Extrapyramidal Tracts; Female; Homovanillic A | 1977 |
Corrections to a 1980 article on CSF monoamine metabolites.
Topics: 3,4-Dihydroxyphenylacetic Acid; Depressive Disorder; Homovanillic Acid; Humans; Hydroxyindoleacetic | 1989 |
Multivariate analysis of monoamine indices in patients with chronic schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Brain; Dopamine; Dopamine beta-Hydroxylase; Dyskinesia, | 1989 |
Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Chronic Disease; Dopamine; Female; Halo | 1985 |
Chemical and structural changes in the brain in patients with movement disorder.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Antipsychotic Agents; Brain; Choline O-Acetyltransfer | 1985 |
CSF dopamine turnover and positive schizophrenic symptoms after withdrawal of long-term neuroleptic treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Brain; Chronic Disease; Dopamine; Femal | 1985 |
Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Blood Platelets; Brain; Debrisoquin; Dopamine; Homovani | 1988 |
Elevation of plasma homovanillic acid level can be detected within four hours after initiation of haloperidol treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Female; Haloperidol; Homovanillic Acid; Humans; Male; Prolact | 1987 |
Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Atrophy; Cerebral Cortex; Dopamine; Female; Homov | 1986 |
Central catecholamines, cognitive impairment, and affective state in elderly schizophrenics and controls.
Topics: 3,4-Dihydroxyphenylacetic Acid; Affect; Aged; Catecholamines; Cognition; Homovanillic Acid; Humans; | 1987 |
Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Brain Chemistry; Catecholamines; Cognition; Dementia; Dopamine | 1985 |